Why Sedana Medical stock moves
Sedana Medical fell slightly without a company-news explanation.
Written after the close on ·
Why today
16,415 news analyzed todaySedana Medical fell slightly without a company-news explanation.
Over the last five trading days the shares rose slightly while OMX Stockholm 30 was roughly flat.
The move was an ordinary size for Sedana Medical.
Across Nasdaq First North Sweden healthcare stocks, the median move over the same window was negative, so sector weakness may have contributed.
Today's move of −1.65% was 0.7 times a normal day's 2.5%. OMX Stockholm 30 moved −1.01% on the same day.
Sedana Medical −1.65%OMX Stockholm 30 −1.01%A little weaker than the market
What analysts expect, and how often they have been right
Analysts’ estimates for Sedana Medical.
Sedana Medical earned more than expected in 4 out of 8 reports.
For comparison, about 46% of reports from Nordic companies beat the estimate in the last three years.
The share moved in the same direction as the earnings surprise in 3 out of 8 reports with a measured move, against about 63% of reports from Nordic companies.
Ratings
Price targets
Latest price 9.53 SEK
Earnings against expectations, and the share’s reaction
Expected EPSAbove estimateBelow estimateAs expectedSEK
Next reported quarter: expected earnings per share of -0.03 SEK (February 11). For the current fiscal year, expected earnings per share changed from -0.29 SEK three months ago to -0.27 SEK now. 2026 estimate: -0.27 SEK. 2027 estimate: -0.08 SEK. One analyst made these estimates. People on the board and in management must report their trades in the share to Finansinspektionen, Sweden's financial supervisor. March 18: Sell about 1.5 m SEK. November 10: Buy about 20 thousand SEK.
Has the share price followed the business?
Price and earnings moved in the same direction: 2 out of 3 years. Across Nordic companies, that happens in about 60% of years. In 2025, the price changed −46% and earnings per share went from -0.11 SEK to -0.60 SEK.
Revenue, profit and market cap
RevenueProfitMarket capHatched bars: analysts’ estimates.bn SEK
Assets, liabilities and market cap
AssetsLiabilitiesMarket capbn SEK
Price and earnings moved in the same direction: 2 out of 3 years.Market cap (Now): 947 m SEKRevenue 2025: 200 m SEK
What the key figures say about Sedana Medical
The figures connect what Sedana Medical earns with what investors pay.
The line shows the share price in the same year, on its own scale. Hatched bars: analysts’ estimates.
Profit divided by the number of shares. Each share represents this much of the earnings.
2022–2025: -0.74 SEK–-0.11 SEK. Peers: Episurf Medical -0.07 SEK, C-Rad 1.41 SEK, Microbot Medical -$0.25. 2026 estimate: -0.27 SEK (-0.27 SEK–-0.27 SEK). 2027 estimate: -0.08 SEK (-0.08 SEK–-0.08 SEK).
What the company sold during the year.
2022–2025: 123 m SEK–200 m SEK. Peers: Episurf Medical 26.1 m SEK, C-Rad 418 m SEK, Microbot Medical $0.3M. 2026 estimate: 207 m SEK (207 m SEK–207 m SEK). 2027 estimate: 260 m SEK (260 m SEK–260 m SEK).
The percentage of revenue left after the costs of running the business.
2022–2025: −84.6%–−16.3%. Peers: Episurf Medical −428.1%, C-Rad 13.1%, Microbot Medical −5348.8%.
Profit as a percentage of shareholders’ money in the company.
2022–2025: −7.1%–−1.1%. Peers: Episurf Medical −91.1%, C-Rad 13.0%, Microbot Medical −32.9%.
What investors pay for each unit the company sells.
2022–2025: 5.10–15.12. Peers: Episurf Medical 34.62, C-Rad 1.89, Microbot Medical 215.47. 2026 estimate: 4.58. 2027 estimate: 3.64.
More key figures
Market cap divided by shareholders’ equity, what remains after liabilities.
2022–2025: 1.13–2.37. Peers: Episurf Medical 0.65, Microbot Medical 1.08.
Cash left after investments, divided by the number of shares.
2022–2025: -2.55 SEK–-0.76 SEK. Peers: Episurf Medical -0.00 SEK, C-Rad 0.39 SEK, Microbot Medical -$0.27.
The percentage of assets financed by shareholders’ equity.
2022–2025: 94.0%–95.7%.
What to watch next, and why
The earnings report shows how Sedana Medical's revenue and profit have changed.
- Earnings report
The earnings report shows how Sedana Medical's revenue and profit have changed.
Add to calendar
More about Sedana Medical
Insider trades
People on the board and in management must report their trades in the share to Finansinspektionen, Sweden's financial supervisor.
- Johan Spetz, CFOSellabout 1.5 m SEK
- Hilde Furberg, board member (closely associated)Buyabout 20 thousand SEK
Earnings report
Next report: · Add to calendar · Google Calendar
On its last 15 report days Sedana Medical usually moved about 7.7%. On a normal day it moves 2.5%.
−3.94% Why? −3.79% −2.30% +11.72%
10,000 SEK in Sedana Medical bought on June 21, 2017 is worth 16,000 SEK today, with dividends reinvested.
What would 10,000 SEK in Sedana Medical be worth today? →
What would 10,000 SEK in Sedana Medical be worth today?
16,000 SEK
with dividends reinvested, bought on June 21, 2017.
At worst it was worth 8,700 SEK (June 29, 2017).
The five biggest days of the journey
· −34.1% · the whole market was unchanged the same day
· −30.8% · the whole market fell 0.5% the same day · report day
· −30.6% · the whole market fell 0.1% the same day · report day
· +29.9% · the whole market fell 0.7% the same day · report day
· −29.6% · the whole market rose 0.7% the same day
Earlier days
+2.14% market −0.11% Sedana Medical rose slightly over the week's trading days, while the broader Stockholm market was roughly flat. Read →
Sedana Medical rose slightly over the week's trading days, while the broader Stockholm market was roughly flat.
Its next earnings report is due on Thursday 11 February 2027.
+2.69% market +0.83% Sedana Medical rose clearly. Read →
Sedana Medical rose clearly.
No company news from the last session explains the move.
The market rose clearly over the same day, so the broader rise likely lifted the stock.
Over the last five trading days, the stock rose clearly while OMX Stockholm 30 rose slightly.
The most recent company news was Pareto Securities cutting its price target, the fair value it sees, to 17 kronor while keeping its buy rating, dated the Monday before the last session.
−1.48% market −0.08% Sedana Medical fell slightly without company news. Read →
Sedana Medical fell slightly without company news.
Over the last five trading days it fell clearly while the market rose slightly, so it moved against the market.
A cut in price target, the fair value an analyst sees, from Pareto Securities came the Monday before the last session, which may have weighed on sentiment.
The share price is still well above its lowest close of the past year, and the next earnings report is due Thursday 11 February 2027.
−3.81% market +3.01% Sedana Medical edged lower over the past week, moving against a clearly rising market. Read →
Sedana Medical edged lower over the past week, moving against a clearly rising market.
Its move was ordinary in size for the stock.
Over the same days, the OMX Stockholm 30 index rose clearly, while the healthcare peers fell by a similar small amount.
The most recent company news was the third-quarter report, which showed sales growth returning, but the shares did not follow it higher.
−6.90% market +0.33% Sedana Medical fell, moving clearly against the market. Read →
Sedana Medical fell, moving clearly against the market.
Over the same days OMX Stockholm 30 rose slightly, so the drop was stock-specific.
The data names no company news from the last session that explains the fall.
Earlier Q3 2026 results, released last week, showed sales growth but a wider operating loss, and the shares fell after that report.
Trading volume was about three times normal, a sign of heavy selling.
+0.20% market +0.96% Sedana Medical moved roughly flat without company news. Read →
Sedana Medical moved roughly flat without company news.
Its shares were little changed while OMX Stockholm 30 rose clearly, so it lagged the market.
The move was an ordinary day for Sedana Medical, well within its usual daily range, on below-normal trading.
Over the last five trading days, the shares were roughly unchanged, in line with a flat market.
+1.89% market +0.41% Sedana Medical rose slightly, moving more than the market. Read →
Sedana Medical rose slightly, moving more than the market.
The move was ordinary for the stock, on heavier trading than usual.
Over the last five trading days, the shares fell slightly, moving in line with a sharply falling OMX Stockholm 30.
The most likely driver is the third-quarter report, published before the session, which showed sales growth returning despite a wider operating loss.
No company news from the session itself explains the small rise.
−3.00% market −3.67% Sedana Medical fell slightly over the last five trading days, moving in line with the broader market, which dropped sharply. Read →
Sedana Medical fell slightly over the last five trading days, moving in line with the broader market, which dropped sharply.
The move was ordinary in size for the stock.
The main driver was likely the third-quarter report published yesterday: sales rose 7%, returning to growth, but the operating loss widened as the company invested in its sales force.
Its US drug review by the FDA, the regulator, is still under way.
−3.94% market −2.51% Sedana Medical fell sharply after its Q3 report. Read →
Sedana Medical fell sharply after its Q3 report.
Sedana Medical is listed on Nasdaq Stockholm and fell sharply in the last session.
The market also fell sharply, so the decline was in line with the broader market.
Its third-quarter report came out that day, showing sales up 7% as growth returned.
Operating loss (EBIT, earnings before interest and tax) widened, which likely weighed on the shares.
+3.81% market −0.89% Sedana Medical rose without company news. Read →
Sedana Medical rose without company news.
In the last session it rose clearly, while OMX Stockholm 30 fell clearly, so it moved against the market.
No company news from that session explains the move.
The next report is on Thursday 22 October 2026, a date to watch.
−5.60% market −0.89% Sedana Medical fell sharply, with no company news explaining it. Read →
Sedana Medical fell sharply, with no company news explaining it.
Sedana Medical is a Nasdaq Stockholm stock in the healthcare sector, which makes medical devices and drugs for patient sedation.
Over the last five trading days the shares fell slightly while the OMX Stockholm 30 index was roughly flat, so the stock lagged the market.
In the last session it fell clearly more than the index, which also fell clearly.
Trading was around its usual level.
Learn more · Why do stocks go up and down?